Matches in Wikidata for { <http://www.wikidata.org/entity/Q37893435> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q37893435 description "article científic" @default.
- Q37893435 description "article scientifique" @default.
- Q37893435 description "articolo scientifico" @default.
- Q37893435 description "artigo científico" @default.
- Q37893435 description "artículu científicu espublizáu n'ochobre de 2011" @default.
- Q37893435 description "bilimsel makale" @default.
- Q37893435 description "scientific article published on October 2011" @default.
- Q37893435 description "vedecký článok" @default.
- Q37893435 description "vetenskaplig artikel" @default.
- Q37893435 description "videnskabelig artikel" @default.
- Q37893435 description "vědecký článek" @default.
- Q37893435 description "wetenschappelijk artikel" @default.
- Q37893435 description "wissenschaftlicher Artikel" @default.
- Q37893435 description "наукова стаття, опублікована в жовтні 2011" @default.
- Q37893435 description "научни чланак" @default.
- Q37893435 description "مقالة علمية نشرت في أكتوبر 2011" @default.
- Q37893435 name "Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6-year period" @default.
- Q37893435 name "Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6-year period" @default.
- Q37893435 type Item @default.
- Q37893435 label "Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6-year period" @default.
- Q37893435 label "Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6-year period" @default.
- Q37893435 prefLabel "Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6-year period" @default.
- Q37893435 prefLabel "Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6-year period" @default.
- Q37893435 P1433 Q37893435-51FB8844-9948-44E8-8CC0-3B7BB659D69E @default.
- Q37893435 P1476 Q37893435-FC374B02-471E-4DF1-86C5-AA02E28F2252 @default.
- Q37893435 P2093 Q37893435-47D8FE33-A123-4740-9F20-EC7390E0443E @default.
- Q37893435 P2093 Q37893435-D1E38404-F9C8-4D48-950F-5ED163A6F74F @default.
- Q37893435 P304 Q37893435-90F7A057-E3D2-41F9-B5FF-B6A9D3BDBBF9 @default.
- Q37893435 P31 Q37893435-66E9E928-F322-4265-8C0F-E80DF288C079 @default.
- Q37893435 P356 Q37893435-9A30FB56-26F7-4351-9265-7A5CA6DC9996 @default.
- Q37893435 P433 Q37893435-1A21FF04-2DA0-418F-964B-D7354A35D794 @default.
- Q37893435 P478 Q37893435-9C1785F4-7868-495E-B561-031F7B4E8E15 @default.
- Q37893435 P577 Q37893435-D8B3E7EA-6734-4A39-8E28-3F933B409963 @default.
- Q37893435 P698 Q37893435-2268C50D-4B21-4AD8-8F4F-86F9D252C439 @default.
- Q37893435 P356 MPA.0B013E31821F66B4 @default.
- Q37893435 P698 21697761 @default.
- Q37893435 P1433 Q15762014 @default.
- Q37893435 P1476 "Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6-year period" @default.
- Q37893435 P2093 "Aaron I Vinik" @default.
- Q37893435 P2093 "Lowell Anthony" @default.
- Q37893435 P304 "987-994" @default.
- Q37893435 P31 Q13442814 @default.
- Q37893435 P356 "10.1097/MPA.0B013E31821F66B4" @default.
- Q37893435 P433 "7" @default.
- Q37893435 P478 "40" @default.
- Q37893435 P577 "2011-10-01T00:00:00Z" @default.
- Q37893435 P698 "21697761" @default.